DB16178InvestigationalProtein Based Therapies
Glymera is under investigation in clinical trial NCT01658501 (Phase 2b Multicenter, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group Study to Assess the PD Response and Safety of Three Dose Levels of...
- Mechanism
- Curator reviewed
Pharmacologically active on Glucagon-like peptide 1 receptor
- Also known as
- Glucagon like peptide-1 Elastin like peptide-120 fusion protein · Glymera · L-Histidylglycyl-L-α-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-α-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-α-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-L-lysyl-L-α-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryp
- Code names
- PB-1023 · PF-1801
Resolves to
Compound
Targets
What you can answer from here — as of July 08, 2026
Which drugs share a target with Froniglutide, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account